ZA200509132B - N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors - Google Patents

N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors

Info

Publication number
ZA200509132B
ZA200509132B ZA200509132A ZA200509132A ZA200509132B ZA 200509132 B ZA200509132 B ZA 200509132B ZA 200509132 A ZA200509132 A ZA 200509132A ZA 200509132 A ZA200509132 A ZA 200509132A ZA 200509132 B ZA200509132 B ZA 200509132B
Authority
ZA
South Africa
Prior art keywords
noradrenaline
serotonin
pyrrolidin
amide derivatives
uptake inhibitors
Prior art date
Application number
ZA200509132A
Inventor
Fish Paul Vincent
Fray Michael Jonathan
Lovering Deborah Jane
Stobie Alan
Wakenhut Florian
Whitlock Gavin Alistair
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27636730&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200509132(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of ZA200509132B publication Critical patent/ZA200509132B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
ZA200509132A 2003-06-17 2005-11-11 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors ZA200509132B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0314048.0A GB0314048D0 (en) 2003-06-17 2003-06-17 Novel compounds

Publications (1)

Publication Number Publication Date
ZA200509132B true ZA200509132B (en) 2007-02-28

Family

ID=27636730

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200509132A ZA200509132B (en) 2003-06-17 2005-11-11 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors

Country Status (9)

Country Link
CN (1) CN1835921A (en)
GB (1) GB0314048D0 (en)
GT (1) GT200400121A (en)
NO (1) NO20060190L (en)
OA (1) OA13178A (en)
RS (1) RS20050924A (en)
TN (1) TNSN05321A1 (en)
UA (1) UA80338C2 (en)
ZA (1) ZA200509132B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008339351B2 (en) * 2007-12-19 2013-02-28 Sumitomo Dainippon Pharma Co., Ltd. Bicyclic heterocyclic derivative

Also Published As

Publication number Publication date
TNSN05321A1 (en) 2007-07-10
GT200400121A (en) 2005-03-03
RS20050924A (en) 2008-04-04
OA13178A (en) 2006-12-13
UA80338C2 (en) 2007-09-10
GB0314048D0 (en) 2003-07-23
CN1835921A (en) 2006-09-20
NO20060190L (en) 2006-01-12

Similar Documents

Publication Publication Date Title
IL172063A0 (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
PT1749818E (en) Phenyl-piperidine derivatives as serotonin reuptake inhibitors
EP1869060A4 (en) Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
AP2048A (en) Diazepinoindole derivatives as kinase inhibitors
IL173381A0 (en) 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
IL172132A0 (en) Thienopyridone derivatives as kinase inhibitors
PL364580A1 (en) Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
HK1071360A1 (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
EP1863769A4 (en) Hsp90 inhibitors, methods of making and uses therefor
IL165515A0 (en) Bisindolyl-maleimid derivatives as kinase inhibitors
AU2003288444A1 (en) Methods and compositions for preventing fracture proppant flowback
AU2003271566A8 (en) Pyrrolopyrazines as kinase inhibitors
IL173904A0 (en) Combinations comprising alpha-2-delta ligands and serotonin/noradrenaline re-uptake inhibitors
GB0314054D0 (en) Amide derivatives as selective serotonin re-uptake inhibitors
IL173521A0 (en) Substituted 2 - carbonylamino - 6 piperidinaminopyidines and substituted 1 - carbonylamino - 3 - piperidinaminobenzenes as 5 - th1f agonists
TWI368482B (en) New 2-pyridinylethylbenzamide derivatives
ZA200606070B (en) Substituted quinolines and their use as mycrobacterial inhibitors
EP1809613A4 (en) Methods of making 2,6-diaryl piperidine derivatives
IL176772A0 (en) Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors
IL154343A0 (en) Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
ZA200703674B (en) Acylated nonadepsipeptides used as lysobactin derivatives
EP1670739A4 (en) Cyclic diamines and derivatives as factor xa inhibitors
PL374581A1 (en) Diaminothiazoles and use thereof as cdk4 inhibitors
HK1089174A1 (en) Benzimidazole-derivatives as factor xa inhibitors
PL373533A1 (en) Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors